How do Parkinson's disease patients manage Ramadan fasting? An observational study

W A Kamel; J Y Al Hashel; P Damier

doi:10.1016/j.neurol.2018.12.008

How do Parkinson's disease patients manage Ramadan fasting? An observational study

Rev Neurol (Paris). 2019 Oct;175(9):560-563. doi: 10.1016/j.neurol.2018.12.008. Epub 2019 Jun 5.

Authors

W A Kamel¹, J Y Al Hashel², P Damier³

Affiliations

¹ Ibn Sina Hospital, Department of Neurology, Kuwait city, Kuwait; Beni-Suef University, Department of Neurology, Beni-Suef, Egypt.
² Ibn Sina Hospital, Department of Neurology, Kuwait city, Kuwait; University of Kuwait, Kuwait City, Kuwait.
³ Inserm, CIC 1413, clinique neurologique, hôpital Laennec, CHU de Nantes, 44093 Nantes, France; University of Nantes, 44035 Nantes, France. Electronic address: [email protected].

PMID: 31176513
DOI: 10.1016/j.neurol.2018.12.008

Abstract

Twenty-four Parkinson's disease (PD) patients who had planned to fast during the 2016 Ramadan were included in this observational study. Twenty patients fasted during the whole Ramadan. Six were able to abstain from drug intakes from dawn to dusk; the others needed 1 or 2 intakes of L-DOPA during the day. There were no serious side effects reported during the Ramadan period. Compared to before Ramadan, there were no significant changes after the fasting period in quality of life (PDQ 39), non-motor symptom scale or clinical impression of severity index scores.

Keywords: Fasting; Parkinson's disease; Ramadan.

Publication types

Observational Study

MeSH terms

Adult
Aged
Circadian Rhythm / physiology
Drug Administration Schedule
Drug-Related Side Effects and Adverse Reactions / etiology
Fasting / physiology*
Female
Follow-Up Studies
Humans
Islam*
Kuwait
Levodopa / administration & dosage
Levodopa / adverse effects
Male
Middle Aged
Parkinson Disease / physiopathology
Parkinson Disease / therapy*
Quality of Life
Religion and Medicine
Self Care / methods*
Surveys and Questionnaires

Substances

Levodopa